The role of GLP-1 receptor agonists in the management of obesity
Originally developed for type 2 diabetes, GLP-1 RAs have gained significant traction globally for obesity treatment.
GLP-1 drugs are helpful for children who are living with severe obesity, research finds
Glucagon-like peptide-1 (GLP-1) receptor agonists mimic the action of a hormone called GLP-1 to reduce appetite and feelings of hunger, slow the release of food from the stomach and increase feelings of fullness after eating.
The causal role of gastroesophageal reflux disease in endometriosis: a bidirectional Mendelian randomization study
Clinical observations have pointed out a probable interrelationship between GERD and endometriosis (6), reporting that women with GERD may experience exacerbation of symptoms after endometriosis treatment https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1522085/full
Boys who are overweight in their early teens risk passing on harmful epigenetic traits to future children
A new study suggests that boys who become overweight in their early teens risk damaging the genes of their future children, increasing their chances of developing asthma, obesity and low lung function.
Severe obesity is on the rise in the US
Obesity is high and holding steady in the U.S., but the proportion of those with severe obesity—especially women—has climbed since a decade ago, according to new government research.
